A systematic review and meta-analysis of Zika virus epidemiology
Zika virus (ZIKV), classified as a priority pathogen by the World Health Organization, is an <i>Aedes</i>-borne arbovirus that can cause neurological complications and birth defects in newborns of mothers infected during pregnancy. We conducted a systematic review of peer-reviewed studies reporting ZIKV epidemiological parameters, transmission models and outbreaks (PROSPERO CRD42023393345) to characterize its transmissibility, seroprevalence, risk factors, disease sequelae and natural history. We performed meta-analyses of the proportions of congenital Zika syndrome, pregnancy loss among ZIKV-infected mothers and symptomatic cases. We extracted information from 574 studies. Across 418 included studies assigned a high-quality score, we extracted 969 parameters, 127 outbreak records and 154 models. Using random-effects models, we estimated proportions of congenital Zika syndrome (4.65%, 95% confidence interval (CI): 3.38-6.67%), pregnancy loss (2.48%, 95% CI: 1.62-3.78%) and symptomatic cases (51.20%, 95% CI: 38.00-64.23%). Seroprevalence estimates (<i>n</i> = 354) were retrieved beyond South America and French Polynesia. Basic reproduction number estimates (<i>n</i> = 77) ranged between 1.12 and 7.4. We found 66 human epidemiological delay estimates, including the intrinsic incubation period (<i>n</i> = 11, range: 4-12.1 days), infectious period (<i>n</i> = 15, range: 3-50 days), extrinsic incubation period (<i>n</i> = 22, range: 5.1-24.2 days) and serial interval (<i>n</i> = 27, range: 7.4-32.9 days). These data are available in the R package 'epireview' (version 1.4.5). We provide a comprehensive systematic summary of ZIKV epidemiology, revealing large heterogeneities and inconsistencies in the reporting of parameter estimates, study designs and parameter definitions and underscoring the need for standardized epidemiological definitions.
Authors
- Tristan Naidoo (ORCID: https://orcid.org/0000-0001-9970-2421)
- Anna-Maria Hartner (ORCID: https://orcid.org/0000-0002-8502-9915)
- Christian Morgenstern (ORCID: https://orcid.org/0000-0003-3735-1130)
- Kelly McCain (ORCID: https://orcid.org/0000-0003-2393-2217)
- Thomas Rawson (ORCID: https://orcid.org/0000-0001-8182-4279)
- Patrick Doohan (ORCID: https://orcid.org/0000-0001-8076-1106)
- Sreejith Radhakrishnan (ORCID: https://orcid.org/0000-0003-0090-562X)
- Keith Fraser (ORCID: https://orcid.org/0000-0002-8933-9750)
- Shazia Ruybal‐Pesántez (ORCID: https://orcid.org/0000-0002-0495-179X)
- H.-S. Fu (ORCID: https://orcid.org/0000-0001-5907-1303)
- Marc Baguelin
- Mantra Kusumgar
- Paul Liétar
- H Juliette T Unwin
- Zulma M Cucunubá
- Sabine van Elsland
- Natsuko Imai-Eaton
- Sangeeta Bhatia
- Adam Kucharski
- Dominic P Dee
- Sequoia I Leuba
- Rebecca K Nash
- Ruth McCabe
- Anne Cori
- Anna Vicco
- Edward S Knock
- Rob Johnson
- Richard J Sheppard
- Sequoia I. Leuba
- Ilaria Dorigatti
- Nuno R. Faria
Institutions
- Program for Appropriate Technology in Health (US)
- Johns Hopkins University (US)
- University of Georgia (US)
- University of California, San Francisco (US)
- Pontificia Universidad Javeriana (CO)
- Robert Koch Institute (DE)
- Public Health England (GB)
- University of Bristol (GB)
- University of Oxford (GB)
- London School of Hygiene & Tropical Medicine (GB)
- UK Health Security Agency (GB)
- Universidad San Francisco de Quito (EC)
- University of Glasgow (GB)
Publication Details
- Journal
- Nature Health
- Published
- 2026-02-13
- DOI
- https://doi.org/10.1038/s44360-025-00051-4
- Primary Topic
- Mosquito-borne diseases and control
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bill and Melinda Gates Foundation
- GAVI Alliance
- Wellcome Trust
- National Institute for Health Research Health Protection Research Unit
- National Institute for Health and Care Research
- British Heart Foundation
- Department of Health and Social Care
- Diabetes UK
- Imperial College London
- European Commission
- Medical Research Council
- European and Developing Countries Clinical Trials Partnership